Covered recipient · General Payments record
THOMAS LELAND LEAVITT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$470.44
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $423.18 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $157.92 | 14 |
| Amgen Inc. | $67.76 | 3 |
| Exact Sciences Corporation | $45.78 | 2 |
| PFIZER INC. | $32.86 | 2 |
| Teleflex LLC | $24.66 | 1 |
| GlaxoSmithKline, LLC. | $22.22 | 1 |
| Merck Sharp & Dohme Corporation | $15.64 | 1 |
| Lilly USA, LLC | $14.95 | 1 |
| Novo Nordisk AS | $14.68 | 1 |
| Daiichi Sankyo Inc. | $13.39 | 1 |
| Acerta Pharma LLC | $13.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.90 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519053 | CMS |
| ABBVIE INC. | $1.86 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519055 | CMS |
| ABBVIE INC. | $4.66 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519057 | CMS |
| ABBVIE INC. | $4.97 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519059 | CMS |
| ABBVIE INC. | $24.33 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519061 | CMS |
| ABBVIE INC. | $6.76 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519063 | CMS |
| ABBVIE INC. | $9.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519065 | CMS |
| ABBVIE INC. | $18.64 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519067 | CMS |
| ABBVIE INC. | $27.80 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519069 | CMS |
| ABBVIE INC. | $5.74 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519071 | CMS |
| ABBVIE INC. | $7.35 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519073 | CMS |
| ABBVIE INC. | $7.42 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519075 | CMS |
| ABBVIE INC. | $27.64 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519077 | CMS |
| ABBVIE INC. | $8.85 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107519079 | CMS |
| Amgen Inc. | $14.65 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117307172 | CMS |
| Amgen Inc. | $20.96 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117307174 | CMS |
| Amgen Inc. | $32.15 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117307176 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.32 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123309138 | CMS |
| Daiichi Sankyo Inc. | $13.39 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089447524 | CMS |
| Exact Sciences Corporation | $19.82 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128383811 | CMS |
| Exact Sciences Corporation | $25.96 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128383815 | CMS |
| GlaxoSmithKline, LLC. | $22.22 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116291763 | CMS |
| Lilly USA, LLC | $14.95 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135895753 | CMS |
| Merck Sharp & Dohme LLC | $15.64 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141966569 | CMS |
| Novo Nordisk Inc | $14.68 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108571276 | CMS |
| PFIZER INC. | $19.07 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131551046 | CMS |
| PFIZER INC. | $13.79 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131552765 | CMS |
| Teleflex LLC | $24.66 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142085690 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.